CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · Real-Time Price · USD
4.190
-0.030 (-0.71%)
Jun 27, 2025, 4:00 PM - Market closed
Company Description
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, focused on designing, engineering, and developing potentially curative cell therapies for cancer patients in the United States.
The company develops CRG-023, a tri-specific CAR T product candidate which is in phase 1 that targets tumor cells with three B-cell malignancies; and allogeneic platform, a universal vector solution designed to effectively limit immune-based rejection to enable durable response of CAR T-cell therapy.
The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022.
CARGO Therapeutics, Inc. was incorporated in 2019 and is based in San Carlos, California.
CARGO Therapeutics, Inc.
| Country | United States |
| Founded | 2021 |
| IPO Date | Nov 10, 2023 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 167 |
| CEO | Anup Radhakrishnan |
Contact Details
Address: 835 Industrial Road, Suite 400 San Carlos, California 94070 United States | |
| Phone | 650 379 6143 |
| Website | cargo-tx.com |
Stock Details
| Ticker Symbol | CRGX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $15.00 |
| CIK Code | 0001966494 |
| CUSIP Number | 14179K101 |
| ISIN Number | US14179K1016 |
| Employer ID | 84-4080422 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Anup Radhakrishnan | Interim Chief Executive Officer, Chief Financial Officer, Secretary and Chief Operating Officer |
| Dr. Crystal L. Mackall M.D. | Co-Founder and Scientific Advisory Board Chair |
| Dr. Robbie Majzner M.D. | Co-Founder and Scientific Advisory Board Member |
| Nancy Goodman J.D. | Founder |
| Dr. Louai Labanieh | Founder |
| Halley E. Gilbert Esq., J.D. | Chief Legal Officer |
| Kari E. Leetch | Chief People Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 20, 2025 | 8-K | Current Report |
| May 15, 2025 | SCHEDULE 13G | Filing |
| May 14, 2025 | SCHEDULE 13G/A | Filing |
| May 14, 2025 | SCHEDULE 13G/A | Filing |
| May 12, 2025 | SCHEDULE 13G/A | Filing |
| May 8, 2025 | 10-Q | Quarterly Report |
| Apr 29, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 29, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 28, 2025 | SCHEDULE 13G | Filing |
| Apr 23, 2025 | SCHEDULE 13G/A | Filing |